Sage Therapeutics Overview

Sage Therapeutics Other Income Expense Net

Other Income/Expense Net for SAGE.

Quarterly Other Income/Expense

$4.32M

↓ 48.89% YoY

As of Jun 30, 2025

Annual Other Income/Expense (TTM)

$23.63M

↑ 243.19% YoY

Trailing 12 months ending Jun 30, 2025

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin